Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease
- 13 July 2016
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 123 (9), 2028-2036
- https://doi.org/10.1016/j.ophtha.2016.05.052
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- MicroRNA miR-466 inhibits Lymphangiogenesis by targeting prospero-related homeobox 1 in the alkali burn corneal injury modelJournal of Biomedical Science, 2015
- An important role of lymphatic vessel activation in limiting acute inflammationBlood, 2011
- Deletion of Vascular Endothelial Growth Factor C (VEGF-C) and VEGF-D Is Not Equivalent to VEGF Receptor 3 Deletion in Mouse EmbryosMolecular and Cellular Biology, 2008
- The Link between Lymphatic Function and Adipose BiologyAnnals of the New York Academy of Sciences, 2008
- Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and LymphangiogenesisInvestigative Ophthalmology & Visual Science, 2007
- Observation of lymphatic vessels in orbital fat of patients with inflammatory conditions: a form fruste of lymphangiogenesis?International Journal of Molecular Medicine, 2004
- The Formation of Lymphatic Vessels and Its Importance in the Setting of MalignancyThe Journal of Experimental Medicine, 2002
- Concurrent Induction of Lymphangiogenesis, Angiogenesis, and Macrophage Recruitment by Vascular Endothelial Growth Factor-C in MelanomaThe American Journal of Pathology, 2001
- Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3The EMBO Journal, 2001
- Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.British Journal of Ophthalmology, 1989